Business

According to the Associated Press, GlaxoSmithKline is extending its "Complete the Cycle" inhaler recycling program to 31 US cities, which were chosen because they account for about a third of all inhaler sales in the US, the company said. Patients will be able to drop off used inhalers at approximately 2,000 pharmacies in those cities. A statement about inhaler … [Read more...] about GSK launches inhaler recycling program in US

On October 17, MannKind Corporation announced a plan to sell 40,000,000 shares of its common stock, plus warrants to purchase up to 30,000,000 shares, in a public offering, which it said may or may not be completed. Each share is being sold with a warrant, for a total price of $2.00/share. The funds raised will be used for on-going trials of Afrezza inhaled insulin. … [Read more...] about MannKind announces public stock offering

Market research firm Frost & Sullivan is presenting its 2012 Global Enabling Technology Award to Alexza Pharmaceuticals for its Staccato thermal vaporization inhaler platform. The award is designed to recognize a company for "developing a technology that enables the creation of new products and applications and/or enhances current products" along with the "potential … [Read more...] about Alexza gets Global Enabling Technology Award from Frost & Sullivan

Contract manufacturer PharmaForm, a subsidiary of Akela Pharma, has announced plans to move from Austin, TX to the San Diego, CA area. The company offers formulation and manufacturing services for numerous dosage forms, including nasal sprays and inhalation powders. PharmaForm President and CEO Rudy J. Emmelot commented, "We are excited about our move to San Diego … [Read more...] about PharmaForm moving to San Diego

The United States' National Aeronautics and Space Administration (NASA) has signed a development and commercialization agreement with Epiomed Therapeutics for intranasal scopolamine. The nasal spray for the treatment of motion sickness is also called INSCOP. According to NASA, it has collected extensive data on motion sickness from the experience of astronauts in … [Read more...] about NASA and Epiomed in deal to develop intranasal scopolamine

Fresenius Kabi has announced the availability of 30 ml vials acetylcysteine inhalation solution, 20%, helping to alleviate a shortage of the product in the US. The company is marketing the inhalation solution in the US under a licensing agreement with Innopharma, whose ANDA was approved by the FDA in September 2012. The company's President and CEO John Ducker … [Read more...] about Fresenius Kabi makes acetylcysteine inhalation solution available

The US Patent and Trade Office has awarded Aegis Therapeutics US Patent No. 8,268,791 for "Alkylglycoside compositions for drug administration." The company is highlighting the patent's coverage of fast-acting intranasal triptan formulations for the treatment of migraine headaches that use Aegis's Intravail transmucosal absorption enhancers. Aegis says that this is … [Read more...] about Aegis gets patent for triptan nasal sprays